Be the first to review “– Adipotide (FTPP / Prohibitin-Targeting Peptidomimetic)” Cancel reply
– Adipotide (FTPP / Prohibitin-Targeting Peptidomimetic)
Price range: $70.00 through $215.00
Product Classification
- Classified as an adipose vascular targeting research compound
Description
Adipotide (FTTP) is a synthetic peptidomimetic designed to induce apoptosis in white adipose tissue vascular endothelial cells.
It binds to cell surface proteins such as prohibiting expressed on adipose vasculature, disrupting nutrient supply.
Research explores fat mass reduction through vascular targeting rather than direct metabolic modulation.
Specifications
- Molecular Type: Synthetic peptidomimetic / vascular targeting compound
- Mechanism: Apoptosis induction via adipose vasculature targeting pathways
Research Notes
- Adipose Reduction: preclinical primate and rodent studies reported reductions in white adipose tissue mass.
- Weight Loss: associated declines in body weight observed in animal models independent of caloric restriction
- Metabolic Parameters: research noted improvements in insulin sensitivity and glycemic control in some models
- Mechanistic Pathway: apoptosis of adipose vascular endothelial cells reduces blood supply supporting adipocyte survival.
Regulatory Statement
For research use only. Not for human or animal consumption.
Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent disease

Reviews
There are no reviews yet.